Emerging Microbes & Infections
Volume 10, 2021 - Issue 1
Open access
4,676
Views
11
CrossRef citations to date
0
Altmetric
Research Article
Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody
Xianmin Menga Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
https://orcid.org/0000-0002-1747-7783
Peipei Wangb Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Yanqing Xionga Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
, Yijun Wua Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
, Xiaoyan Lina Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
, Song Lub Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Ruowan Lib Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Bei Zhaob Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Jing Liub Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Shaoqing Zengb Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Liyan Zenga Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
, Yan Wua Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
, Yan Lua Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China
, Jinchao Zhangb Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of China
, Datao Liub Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of ChinaCorrespondence[email protected]
, Shuhai Wangb Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People’s Republic of ChinaCorrespondence[email protected]
& Hongzhou Lua Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-8308-5534
Pages 1638-1648
|
Received 29 May 2021, Accepted 23 Jul 2021, Published online: 18 Aug 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.